Literature DB >> 11120399

Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice.

C Betancur1, I Lépée-Lorgeoux, M Cazillis, D Accili, S Fuchs, W Rostène.   

Abstract

Exposure to psychostimulants and antipsychotics increases neurotensin (NT) gene expression in the striatum and nucleus accumbens. To investigate the contribution of D(3) receptors to these effects we used mice with targeted disruption of the D(3) receptor gene. Basal NT mRNA expression was similar in D(3) receptor mutant mice and wild-type animals. Acute administration of haloperidol increased NT gene expression in the striatum in D(3)+/+, D(3)+/- and D(3)-/- mice. Similarly, acute cocaine and amphetamine induced NT mRNA expression in the nucleus accumbens shell and olfactory tubercle to a comparable extent in D(3) mutants and wild-type mice. Daily injection of cocaine for seven days increased NT mRNA in a restricted population of neurons in the dorsomedial caudal striatum of D(3)+/+ mice, but not in D(3)-/- and D(3)+/- animals. No differences were observed between D(3) receptor mutant mice and wild-type littermates in the locomotor activity and stereotyped behaviors induced by repeated cocaine administration. These findings demonstrate that dopamine D(3) receptors are not necessary for the acute NT mRNA response to drugs of abuse and antipsychotics but appear to play a role in the regulation of NT gene induction in striatal neurons after repeated cocaine. In addition, our results indicate that the acute locomotor response to cocaine and development of psychostimulant-induced behavioral sensitization do not require functional D(3) receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11120399      PMCID: PMC2556380          DOI: 10.1016/S0893-133X(00)00179-2

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  61 in total

1.  Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain.

Authors:  J Diaz; D Lévesque; C H Lammers; N Griffon; M P Martres; J C Schwartz; P Sokoloff
Journal:  Neuroscience       Date:  1995-04       Impact factor: 3.590

2.  Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy.

Authors:  K K Yung; J P Bolam; A D Smith; S M Hersch; B J Ciliax; A I Levey
Journal:  Neuroscience       Date:  1995-04       Impact factor: 3.590

Review 3.  Molecular mechanisms of drug reinforcement and addiction.

Authors:  D W Self; E J Nestler
Journal:  Annu Rev Neurosci       Date:  1995       Impact factor: 12.449

4.  Preexposure to, but not cotreatment with, the neurotensin antagonist SR 48692 delays the development of cocaine sensitization.

Authors:  B A Horger; J R Taylor; J D Elsworth; R H Roth
Journal:  Neuropsychopharmacology       Date:  1994-11       Impact factor: 7.853

5.  A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.

Authors:  D Accili; C S Fishburn; J Drago; H Steiner; J E Lachowicz; B H Park; E B Gauda; E J Lee; M H Cool; D R Sibley; C R Gerfen; H Westphal; S Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

6.  A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons.

Authors:  D Lévesque; M P Martres; J Diaz; N Griffon; C H Lammers; P Sokoloff; J C Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions.

Authors:  K M Merchant; D J Dobie; F M Filloux; M Totzke; M Aravagiri; D M Dorsa
Journal:  J Pharmacol Exp Ther       Date:  1994-10       Impact factor: 4.030

8.  Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine D2 receptor antagonist.

Authors:  D J Sirinathsinghji; R Schuligoi; R P Heavens; A Dixon; S D Iversen; R G Hill
Journal:  Neuroscience       Date:  1994-09       Impact factor: 3.590

9.  Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens.

Authors:  J Diaz; D Lévesque; N Griffon; C H Lammers; M P Martres; P Sokoloff; J C Schwartz
Journal:  Eur J Neurosci       Date:  1994-08-01       Impact factor: 3.386

10.  Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability.

Authors:  D C Hoffman; H Donovan
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

View more
  11 in total

Review 1.  Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.

Authors:  John L Waddington; Colm O'Tuathaigh; Gerard O'Sullivan; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

Review 2.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

3.  Relative expression of D3 dopamine receptor and alternative splice variant D3nf mRNA in high and low responders to novelty.

Authors:  Laurel M Pritchard; Aaron D Logue; Benjamin C Taylor; Rebecca Ahlbrand; Jeffrey A Welge; Yang Tang; Frank R Sharp; Neil M Richtand
Journal:  Brain Res Bull       Date:  2006-07-13       Impact factor: 4.077

4.  β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors.

Authors:  Lauren M Slosky; Yushi Bai; Krisztian Toth; Caroline Ray; Lauren K Rochelle; Alexandra Badea; Rahul Chandrasekhar; Vladimir M Pogorelov; Dennis M Abraham; Namratha Atluri; Satyamaheshwar Peddibhotla; Michael P Hedrick; Paul Hershberger; Patrick Maloney; Hong Yuan; Zibo Li; William C Wetsel; Anthony B Pinkerton; Lawrence S Barak; Marc G Caron
Journal:  Cell       Date:  2020-05-28       Impact factor: 41.582

5.  Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats.

Authors:  Pat Bauco; Pierre-Paul Rompré
Journal:  Psychopharmacology (Berl)       Date:  2003-04-08       Impact factor: 4.530

Review 6.  Neurotensin in reward processes.

Authors:  María Luisa Torruella-Suárez; Zoe A McElligott
Journal:  Neuropharmacology       Date:  2020-02-11       Impact factor: 5.250

7.  Dose-response analysis of locomotor activity and stereotypy in dopamine D3 receptor mutant mice following acute amphetamine.

Authors:  Robert K McNamara; Aaron Logue; Kevin Stanford; Ming Xu; Jianhua Zhang; Neil M Richtand
Journal:  Synapse       Date:  2006-10       Impact factor: 2.562

8.  Altered neurotensin mrna expression in mice lacking the dopamine transporter.

Authors:  C Roubert; C Spielewoy; P Soubrié; M Hamon; B Giros; C Betancur
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

9.  The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats.

Authors:  Mark J Millan; Laetitia Seguin; Alain Gobert; Didier Cussac; Mauricette Brocco
Journal:  Psychopharmacology (Berl)       Date:  2004-02-19       Impact factor: 4.530

10.  Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease.

Authors:  Tatyana D Sotnikova; Jean-Martin Beaulieu; Larry S Barak; William C Wetsel; Marc G Caron; Raul R Gainetdinov
Journal:  PLoS Biol       Date:  2005-08-02       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.